{"id":19297,"date":"2021-12-17T07:44:31","date_gmt":"2021-12-17T12:44:31","guid":{"rendered":"https:\/\/medicarereport.org\/?p=19297"},"modified":"2021-12-17T07:44:33","modified_gmt":"2021-12-17T12:44:33","slug":"cdc-narrows-use-of-jj-vaccine-due-to-concerns-about-rare-blood-clots","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=19297","title":{"rendered":"CDC narrows use of J&#038;J vaccine due to concerns about rare blood clots"},"content":{"rendered":"\n<p>(By Vanessa Romo and Scott Hensley for NPR)<\/p>\n\n\n\n<p>The Centers for Disease Control and Prevention accepted advice from a panel of experts to recommend the use of the Moderna and Pfizer-BioNTech COVID-19 vaccines over the Johnson &amp; Johnson jab, following growing concerns about rare blood clots. Continue reading <a href=\"https:\/\/www.npr.org\/sections\/coronavirus-live-updates\/2021\/12\/16\/1064909742\/cdc-vote-narrow-use-of-johnson-and-johnson-covid-vaccine\" data-type=\"URL\" data-id=\"https:\/\/www.npr.org\/sections\/coronavirus-live-updates\/2021\/12\/16\/1064909742\/cdc-vote-narrow-use-of-johnson-and-johnson-covid-vaccine\">here&#8230;<\/a><\/p>\n\n\n\n<p class=\"has-text-align-center\"><img loading=\"lazy\" decoding=\"async\" width=\"275\" height=\"100\" class=\"wp-image-3902\" style=\"width: 275px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png 152w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo-150x55.png 150w\" sizes=\"auto, (max-width: 275px) 100vw, 275px\" \/><\/p>\n\n\n\n<pre class=\"wp-block-preformatted\"><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Vanessa Romo and Scott Hensley for NPR) The Centers for Disease Control and Prevention accepted advice from a panel<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44,15],"tags":[],"class_list":["post-19297","post","type-post","status-publish","format-standard","hentry","category-cdc","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19297"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19297\/revisions"}],"predecessor-version":[{"id":19298,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19297\/revisions\/19298"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}